Analysis of the type of luminescence of ANA antinuclear antibodies in SLE patients showed the presence of the following luminescence patterns: homogeneous (39.0%), speckled (31.0%), speckled/homogeneous (26.0%), and peripheral (3.0%) (Table 2). The gene discussed is BTG3; the disease is systemic lupus erythematosus.